• Corpus ID: 1760349

Effects of Letrozole Compared with Danazol on Patients with Confirmed Endometriosis: A Randomized Clinical Trial

@inproceedings{Roghaei2010EffectsOL,
  title={Effects of Letrozole Compared with Danazol on Patients with Confirmed Endometriosis: A Randomized Clinical Trial},
  author={Mohamad Ali Roghaei and Hatav Ghasemi Tehrany and Aliakbar Taherian and Navid Koleini},
  year={2010}
}
Background: Letrozole is an aromatase inhibitor which can decrease estrogen production in peripheral tissues and endometriosis. Danazol, as an androgen, inhibits estrogen production in ovaries and recently has been introduced as an aromatase inhibitor. This study was designed to compare the effects of Danazol with Letrozole on endometriosis symptom relief. Materials and Methods: This study was a randomized clinical trial in which 105 patients with confirmed endometriosis were randomly assigned… 

Figures and Tables from this paper

Advances in pharmacotherapy for treating endometriosis
TLDR
The treatments most recently proposed for endometriosis will be described in detail, including gonadotropin-releasing hormone (GnRH) antagonists, aromatase inhibitors (AIs) and the flexible extended combined oral contraceptive.
Aromatase inhibitors for the treatment of endometriosis: a systematic review about efficacy, safety and early clinical development
TLDR
Based on the critical role of estrogens and the rate-limiting step in the production of the estrogens represented by the aromatase enzyme, AIs are a potential therapeutic option for women affected by endometriosis, but further research is needed to clarify the efficacy and safety of AIs.
Are aromatase inhibitors effective in endometriosis treatment?
TLDR
Because there is no strong evidence of their efficacy or benefit compared to other molecules in existing clinical trials, AIs need to be investigated further in well-designed studies to confirm/disprove their hypothetical impact on endometriotic lesions.
Potential role of aromatase inhibitors in the treatment of endometriosis
TLDR
Few studies are available regarding the use of AIs to treat endometriosis-associated infertility, and larger multicenter randomized trials using AIs for the treatment of endometRIosis- associated infertility are needed to clarify its effect.
Potential role of aromatase inhibitors in the treatment of endometriosis
TLDR
Few studies are available regarding the use of AIs to treat endometriosis-associated infertility, and larger multicenter randomized trials using AIs for the treatment of endometRIosis- associated infertility are needed to clarify its effect.
Use of aromatase inhibitors to treat endometriosis-related pain symptoms: a systematic review
TLDR
In conclusion, AIs effectively reduce the severity of endometriosis-related pain symptoms and future investigations should clarify whether the long-term administration of AIs is superior to currently available endocrine therapies in terms of improvement of pain, adverse effects and patient satisfaction.
Investigational drugs for the treatment of endometriosis, an update on recent developments
TLDR
This review aims to offer the reader a complete and updated overview on new investigational drugs and early molecular targets for the treatment of endometriosis and describes the pre-clinical and clinical development of these agents.
Endometriosis: alternative methods of medical treatment
TLDR
There is a need to find effective treatments that do not block the ovarian function and, among new hormonal drugs, association to aromatase inhibitors could be effective in the treatment of women who do not respond to conventional therapies.
“Per vaginam” topical use of hormonal drugs in women with symptomatic deep endometriosis: a narrative literature review
TLDR
The vaginal route represents a scarcely explored modality for drug administration and high local hormonal concentrations might achieve a greater effect on endometriotic lesions compared with alternative routes.
...
...

References

SHOWING 1-10 OF 21 REFERENCES
Letrozole combined with norethisterone acetate compared with norethisterone acetate alone in the treatment of pain symptoms caused by endometriosis.
TLDR
The combination drug regimen was more effective in reducing pain and deep dyspareunia than norethisterone acetate; however, letrozole caused a higher incidence of adverse effects, cost more and did not improve patients' satisfaction or influence recurrence of pain.
Successful treatment of refractory endometriosis-related chronic pelvic pain with aromatase inhibitors in premenopausal patients.
  • A. Verma, J. Konje
  • Medicine
    European journal of obstetrics, gynecology, and reproductive biology
  • 2009
Danazol for pelvic pain associated with endometriosis.
TLDR
Treatment with danazol (including adjunctive surgical therapy) was effective in relieving painful symptoms related to endometriosis when compared to placebo, however, its use is limited by the occurrence of androgenic side effects.
[Aromatase inhibitors--theoretical concept and present experiences in the treatment of endometriosis].
TLDR
Specific aromatase inhibitors or selective COX-2 inhibitors are of great interest to be studied in clinical trials in premenopausal woman with endometriosis to extend the spectrum of currently available treatment options.
Endometriosis: current therapies and new pharmacological developments.
TLDR
Combined oral contraceptives and progestins, based on their favourable safety profile, tolerability and cost, should be considered as first-line options, as an alternative to surgery and for post-operative adjuvant use.
Endometriosis: current and future medical therapies.
Aromatase inhibitors: possible future applications
TLDR
Aromatase inhibitors are predicted to become the gold standard in the treatment of estrogen‐dependent diseases in reproductive medicine in the near future.
...
...